AstraZeneca, Aji Bio-Pharma Expand Mfg. Agreement

Ajinomoto Bio-Pharma Services, a provider of biopharmaceutical contract development and manufacturing services, entered an expanded manufacturing agreement with AstraZeneca to include drug product manufacturing.

This agreement expands the scope of Aji Bio-Pharma's service offerings to AstraZeneca to include aseptic fill finish services at its San Diego, CA facility, in addition to small molecule manufacturing services proceeding in Belgium.

"We are excited to expand our manufacturing agreement with AstraZeneca and to support them with additional service offerings," said Magnus Busch, Global Account Manager, Ajinomoto Bio-Pharma Services . "Our San Diego team is proud to join our Belgium colleagues in support of AstraZeneca. This expanded agreement builds on our commitment to be a leading, trusted, innovative partner to our clients."